Overview
Auxilium Health is building Aer™, a biomaterial platform positioned for healthcare applications. The company’s available funding context centers on advancing this platform, with no disclosed details on specific products, clinical indications, or commercial deployment. The company closed an oversubscribed seed round reported at $3.4 million, with total raised listed at about $3 million across one round. Its differentiation is framed around the Aer™ biomaterial platform rather than an AI software offering.
Funding History
Auxilium Health Closes Oversubscribed $3.4 Million Seed Round to Advance Its Aer™ Biomaterial Platform
Frequently Asked Questions
- How much has Auxilium Health raised in total?
- Auxilium Health has raised a total of $3M across 1 funding round.
- What does Auxilium Health do?
- Auxilium Health is building Aer™, a biomaterial platform positioned for healthcare applications. The company’s available funding context centers on advancing this platform, with no disclosed details on specific products, clinical indications, or commercial deployment. The company closed an oversubscribed seed round reported at $3.4 million, with total raised listed at about $3 million across one round. Its differentiation is framed around the Aer™ biomaterial platform rather than an AI software offering.
- Where is Auxilium Health headquartered?
- Auxilium Health is headquartered in San Francisco, CA.
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.